Diagnos Inc.
DGNOF
$0.23
$0.026.95%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.82% | -47.09% | -32.65% | -21.50% | -21.11% |
| Total Depreciation and Amortization | -2.48% | -1.27% | 0.11% | 10.87% | 25.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.25% | 1.39% | 6.32% | 16.85% | 30.49% |
| Change in Net Operating Assets | -2,001.23% | 170.32% | -247.87% | -134.12% | -94.69% |
| Cash from Operations | -59.33% | -59.71% | -63.34% | -43.27% | -30.78% |
| Capital Expenditure | -29.11% | -78.87% | -22.22% | 52.24% | 60.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 208.18% | -385.13% | -58,902.63% | -945.55% | -459.11% |
| Cash from Investing | 206.69% | -371.22% | -18,824.37% | -1,035.78% | -416.69% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -576.50% | -549.62% | -185.95% | 31.87% | 29.15% |
| Issuance of Common Stock | -30.58% | 123.46% | 345.25% | 444.14% | 1,017.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.03% | 1.64% | -8.72% | -14.39% | -63.78% |
| Cash from Financing | -53.03% | 106.54% | 208.24% | 220.50% | 109.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.65% | 96.11% | -51.90% | 62.12% | 730.90% |